Related Experiment Video
Updated: May 15, 2026

14:55
Analysis of Minerals Produced by hFOB 1.19 and Saos-2 Cells Using Transmission Electron Microscopy with Energy Dispersive X-ray Microanalysis
Published on: June 24, 2018
Microcalcifications in breast cancer: Lessons from physiological mineralization
1Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, 123 St. Stephen's Green, Dublin 2, Ireland.
Bone
|January 22, 2013
Summary
The formation of hydroxyapatite microcalcifications in breast tissue is not fully understood. Studying physiological mineralization may reveal insights into these early breast cancer markers.
Area of Science:
- Biochemistry
- Oncology
- Mineralization
Background:
- Mammographic microcalcifications are key for early breast cancer detection.
- Two types, calcium oxalate and hydroxyapatite, are identified; hydroxyapatite is linked to malignancy.
- The formation mechanism of hydroxyapatite in mammary tissue is largely unknown.
Purpose of the Study:
- To explore the formation mechanisms of hydroxyapatite microcalcifications in breast tissue.
- To bridge knowledge gaps between physiological mineralization and mammary calcification genesis.
- To understand the significance of microcalcifications as early breast cancer indicators.
Main Methods:
- Review of existing literature on physiological mineralization.
- Juxtaposition of bone mineralization processes with mammary microcalcification formation.
- Analysis of current understanding of hydroxyapatite genesis in breast tissue.
Main Results:
- Hydroxyapatite microcalcifications are associated with both benign and malignant breast tumors.
- Physiological mineralization, like bone formation by osteoblasts, involves hydroxyapatite deposition.
- Understanding these processes could illuminate microcalcification origins.
Conclusions:
- Further research into hydroxyapatite formation mechanisms is crucial.
- Elucidating microcalcification genesis can enhance their role in early cancer detection.
- This knowledge is vital for understanding a unique early marker of breast cancer.

